血红蛋白和内毒素水平预测了酒精性肝硬化患者的萨科佩尼亚发生情况
Akihiko Shibamoto1, Tadashi Namisaki1, Junya Suzuki1
1Department of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, Japan.
Diagnostics (Basel, Switzerland)
|July 14, 2023
概括
血红蛋白 (Hb) 水平可以预测肝硬化 (LC) 患者的肉症. 将Hb与内毒素活性 (EA) 结合使用可能会改善酒精性肝硬化 (AC) 患者的预测.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 老年病的医生 老年病的医生
- 临床营养学 临床营养学
背景情况:
- 酒精是肝硬化的主要危险因素.
- 麻症是LC患者常见的并发症,影响预后.
- 识别可靠的代孕标志物对于LC中的sarcopenia至关重要.
研究的目的:
- 在肝硬化患者中识别了缩症的替代标记物.
- 为了比较酒精性肝硬化 (AC) 和非酒精性肝硬化 (NAC) 患者之间的sarcopenia风险因素.
- 为了评估血红蛋白 (Hb) 和内毒素活性 (EA) 的预测性表现.
主要方法:
- 在451名LC患者 (149名AC,302名NAC) 中评估了手握强度和骨肌肉质量.
- 使用EA测定测量了内毒素活性 (EA) 水平.
- 分析了麻症的风险因素和Hb和EA的预测准确性.
主要成果:
- 萨科佩尼亚的危险因素包括年龄,性别,疾病严重程度 (CP-C LC),低Hb和EA升高.
- 在所有LC患者中,Hb水平预测了78.1%的准确性.
- 在AC患者中,Hb以83.6%的准确度预测了肉症,通过与EA结合而改善.
结论:
- 血红蛋白 (Hb) 是肝硬化 (LC) 中的潜在预测因子.
- 内毒素活性 (EA) 可能增强酒精性肝硬化 (AC) 中的萨科佩尼亚预测.
- 需要进一步的研究来验证这些标志物在不同的LC群体中的有效性.
更多相关视频
08:37Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
366
04:01Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
Published on: June 14, 2024
793
相关概念视频
Factors Affecting Protein-Drug Binding: Patient-Related Factors
83
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
83
Oxygen Transport in the Blood
2.8K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
2.8K
